IRIS
OTTANA', Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.787
EU - Europa 3.850
AS - Asia 3.082
SA - Sud America 1.480
AF - Africa 85
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.296
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.692
SG - Singapore 1.319
BR - Brasile 1.297
IE - Irlanda 1.049
SE - Svezia 951
CN - Cina 822
HK - Hong Kong 425
UA - Ucraina 394
DE - Germania 388
IT - Italia 253
FI - Finlandia 221
RU - Federazione Russa 183
VN - Vietnam 170
GB - Regno Unito 144
PL - Polonia 74
IN - India 63
FR - Francia 58
AR - Argentina 53
CA - Canada 41
EC - Ecuador 40
BD - Bangladesh 33
MX - Messico 31
IQ - Iraq 30
TR - Turchia 30
AT - Austria 27
JP - Giappone 25
CO - Colombia 24
MA - Marocco 24
UZ - Uzbekistan 23
IR - Iran 21
VE - Venezuela 21
PK - Pakistan 19
ID - Indonesia 18
BE - Belgio 17
NL - Olanda 17
CZ - Repubblica Ceca 15
ZA - Sudafrica 15
KE - Kenya 14
CL - Cile 12
KR - Corea 11
PY - Paraguay 10
UY - Uruguay 9
AZ - Azerbaigian 8
DZ - Algeria 8
JO - Giordania 8
LT - Lituania 8
AU - Australia 7
BO - Bolivia 7
EG - Egitto 7
ES - Italia 7
PE - Perù 7
TN - Tunisia 7
CH - Svizzera 6
GR - Grecia 6
IL - Israele 6
JM - Giamaica 6
KZ - Kazakistan 6
LV - Lettonia 6
NO - Norvegia 6
AE - Emirati Arabi Uniti 5
NP - Nepal 5
RS - Serbia 5
CR - Costa Rica 4
LB - Libano 4
OM - Oman 4
AL - Albania 3
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
LK - Sri Lanka 3
PT - Portogallo 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
HR - Croazia 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
GE - Georgia 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
Totale 14.289
Salva come PNG Salva come JPEG
Città #
Dublin 1.048
Jacksonville 782
Chandler 712
Dallas 693
Nyköping 594
Singapore 587
Ashburn 477
Dearborn 434
Hong Kong 424
Beijing 364
Princeton 181
Medford 176
Cambridge 172
Los Angeles 140
The Dalles 98
Des Moines 97
Ann Arbor 94
Boardman 92
Buffalo 88
São Paulo 83
Munich 82
Ho Chi Minh City 77
Warsaw 70
Messina 64
San Mateo 61
New York 56
Moscow 54
Jinan 49
Wilmington 46
Belo Horizonte 45
Turku 39
Tianjin 38
Rio de Janeiro 36
Woodbridge 33
Lancaster 25
Vienna 25
Curitiba 24
Redondo Beach 24
Shenyang 24
Haikou 23
Nanjing 23
Brasília 20
Seattle 20
Hanoi 19
Salvador 19
Tashkent 19
Brussels 17
Phoenix 17
Tokyo 17
Hebei 16
Houston 16
St Petersburg 16
Ardabil 15
Santa Clara 15
Baghdad 14
Atlanta 13
Campinas 13
Chennai 13
Fuzhou 12
Guangzhou 12
Milan 12
Ningbo 12
Quito 12
Taiyuan 12
Taizhou 12
Washington 12
Boston 11
Düsseldorf 11
Hefei 11
London 11
Montreal 11
Porto Alegre 11
Brooklyn 10
Dhaka 10
Francofonte 10
Frankfurt am Main 10
Manaus 10
Nanchang 10
Pune 10
Sorocaba 10
Stockholm 10
Windsor 10
Bremen 9
Chemnitz 9
Chicago 9
Contagem 9
Denver 9
Fortaleza 9
Goiânia 9
Guayaquil 9
Istanbul 9
Johannesburg 9
Nairobi 9
Orem 9
Pelotas 9
Praia Grande 9
San Francisco 9
Zhengzhou 9
Amman 8
Augusta 8
Totale 8.955
Salva come PNG Salva come JPEG
Nome #
Synthesis of tertiary alkyl-substituted acetylenes by electrophilic addition to silylacetylenes 174
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 169
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 145
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 135
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 130
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 129
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 129
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 128
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 127
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 124
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 124
4-Carbossiamido-9-fluorenoni: proprietà anti-HSV-2 e immunostimolanti 123
9-fluorenon-4-carboxamides: synthesis, conformational analysis, anti-HSV-2, and immunomodulatory evaluation. Note II 123
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 120
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 119
(5-Arylidene-2,4-dioxothiazolidin-3-yl)acetic acids as aldose reductase inhibitors 119
Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures 119
2-(4-pyridyl)-Delta(2)-1,3,4-oxadiazolines from isonicotinoylhydrazones and diazomethane as potential antimycobacterial and anti-HIV agents .5. 118
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 116
3,3'-bi(1,3-thiazolidin-4-one) system. VIII. 3,3'-(1,2-ethanediyl) derivatives and corresponding 1,1'-disulfones: Synthesis, stereochemistry and antiinflammatory activity 116
3-ARYL-5-ARYLIDENE-2-THIOXO-4-IMIDAZOLIDINONE DERIVATIVES AS NEW PTP1B ALLOSTERIC INHIBITORS 116
2,4-Thiazolidinediones as in vitro ALR2 inhibitors for the treatment of diabetic complications 115
2,4-thiazolidinedione and 2-thioxo-4-thiazolidinone derivatives as aldose reductase inhibitors in the search for drugs to prevent long-term diabetes complications. 115
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 113
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 113
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 111
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 110
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 109
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 108
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 108
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 106
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications 106
Biocatalysed synthesis of beta-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2 properties 105
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 104
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 104
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatase inhibitors. 103
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 101
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 101
AMINOPYRAZINYL DERIVATIVES - SYNTHESIS AND EVALUATION OF ANTIINFLAMMATORY AND RELATED ACTIVITIES 99
Structure of Aldehyde Reductase in Ternary Complex with a 5-Arylidene-2,4-thiazolidinedione Aldose Reductase Inhibitor 99
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 98
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. 97
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 96
Design and synthesis of DNA-intercalating 9-fluoren-beta-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agents 96
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications 96
Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions 96
An unexpected reaction between 2,3-dihydro-2,2,4-trimethyl-1H-1,5-benzodiazepine and mercaptoacetic acid 95
In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B 95
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 94
Design and synthesis of dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B 94
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 93
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents 93
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 92
Electronegativity of zeolites in relation to catalytic activity in the conversion of methanol to hydrocarbons 92
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 91
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 91
(5-Arylidene-2-thioxo-4-oxothiazolidin-3-yl)acetic acids endowed with chondroprotective and matrix metalloproteinase inhibitory activities 90
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 90
Comparative activity of 5-arylidene-2-thioxo-4-thiazolidinone derivatives in chondrocytes and cartilage: MMP-3 inhibition and determination of GAGs release. 89
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 89
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 87
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 87
Utilization of zeolites in agriculture. Part II: Influence in spinach growing. 87
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 87
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 86
New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells 86
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 85
HALOGENATED ISONIAZID DERIVATIVES .2. UNUSUAL SYNTHESIS OF DELTA(2)-1,3,4-OXADIAZOLINE DERIVATIVES FROM ISONICOTINOYLHYDRAZONES AND DIAZOMETHANE 85
Sintesi di nuovi inibitori dell’aldoso reduttasi come agenti per il trattamento delle complicazioni diabetiche. 85
Non-carboxylic acid 5-arylidene-2,4-thiazolidinedione derivatives as aldose reductase inhibitors 85
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 85
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 84
Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells 83
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 82
Valutazione dell'attività antidegenerativa di 2-tiosso-4-tiazolidinoni su colture di condrociti umani 82
Sintesi di idrocarburi da metanolo su zeoliti commerciali. Relazione fra attività catalitica e acidità 82
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 81
VALUTAZIONE DI COX-2 SELETTIVITÀ SU 3,3'-(1,2-ETANEDIIL)-BIS[2-(3,4-DIMETOSSIFENIL)-4-TIAZOLIDINONI] CHIRALI 81
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 81
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 81
Low Molecular Weight Phosphotyrosine Protein Phosphatases as Emerging Targetsfor the Design of Novel Therapeutic Agents 81
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 80
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 80
Sintesi di 5-ariliden-2-fenilimino-4-tiazolidinoni attivi come inibitori di protein tirosina fosfatasi. 80
Nuovi derivati 5-feniletossibenziliden-4-tiazolidinonici attivi come inibitori della protein tirosina fosfatasi 1B. 80
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 79
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 79
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 79
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 79
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 78
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 77
In vitro Antimycobacterial Activity of Isoniazid-related Metalchelates 77
Progettazione e sintesi di 5-ariliden-4-tiazolidinoni e analoghi come inibitori di protein tirosina fosfatasi 77
Sintesi e valutazione di derivati 2,4-tiazolidindionici non carbossilici come inibitori dell'aldoso reduttasi 77
Sintesi e valutazione in vitro di 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori di protein tirosina fosfatasi 76
HALOGENATED ISONIAZID DERIVATIVES AS POSSIBLE ANTIMYCOBACTERIAL AND ANTI-HIV AGENTS .3. 76
Azione insulinomimetica di acidi [4-(5-ariliden-2-arilimino-4-ossotiazolidin-3-il)metil]benzoici attivi come inibitori delle fosfatasi PTP1B e LMW-PTP 76
HALOGENATED ISONIAZID DERIVATIVES .4. 1-METHYLIDENEAMINO-2- TRIFLUOROMETHYLAZIRIDINES FROM ISONICOTINOYLHYDRAZONES AND DIAZOMETHANE 75
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 75
Protein-tyrosine phosphatase-1B mediates sleep fragmentation-induced insulin resistance and visceral adipose tissue inflammation in mice 74
Totale 9.837
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.462
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021537 0 0 0 0 0 128 18 94 29 117 110 41
2021/20221.073 6 136 34 42 61 5 72 43 13 106 168 387
2022/20232.957 234 285 143 263 198 312 68 129 1.219 13 64 29
2023/2024514 37 94 75 41 57 96 7 27 0 15 6 59
2024/20253.128 62 25 52 167 140 71 59 712 838 187 234 581
2025/20263.300 389 677 716 795 655 68 0 0 0 0 0 0
Totale 14.388